Alberto Emanuel Bacusca1,2, Andrei Tarus1,2, Alexandru Burlacu2,3, Mihail Enache1,2, Grigore Tinica1,2. 1. Department of Cardiovascular Surgery, Cardiovascular Diseases Institute, 700503 Iasi, Romania. 2. Faculty of Medicine, University of Medicine and Pharmacy "Grigore T Popa", 700115 Iasi, Romania. 3. Department of Interventional Cardiology, Cardiovascular Diseases Institute, 700503 Iasi, Romania.
Abstract
(1) Background: Tricuspid regurgitation (TR) is the most frequent valvulopathy in heart transplant recipients (HTX). We aimed to assess the influence of prophylactic donor heart tricuspid annuloplasty (TA) in orthotopic HTX (HTX-A), comparing the outcomes with those of HTX patients. (2) Methods: Electronic databases of PubMed, EMBASE, and SCOPUS were searched. The endpoints were as follows: the overall rate of postprocedural TR (immediate, one week, six months, and one year after the procedure), postoperative complications (permanent pacemaker implantation rate, bleeding), redo surgery for TR, and mortality. (3) Results: This meta-analysis included seven studies. Immediate postprocedural, one-week, six-month and one-year tricuspid insufficiency rates were significantly lower in the HTX-A group. There was no difference in permanent pacemaker implantation rate between the groups. The incidence of postoperative bleeding was similar in both arms. The rate of redo surgery for severe TR was reported only by two authors. In both publications, the total number of events was higher in the HTX cohort, meanwhile pooled effect analysis showed no difference among the intervention and control groups. Mortality at one year was similar in both arms. (4) Conclusion: Our study showed that donor heart TA reduces TR incidence in the first year after orthotopic heart transplantation without increasing the surgical complexity. This is a potentially important issue, given the demand for heart transplants and the need to optimize outcomes when this resource is scarce.
(1) Background: Tricuspid regurgitation (TR) is the most frequent valvulopathy in heart transplant recipients (HTX). We aimed to assess the influence of prophylactic donor heart tricuspid annuloplasty (TA) in orthotopic HTX (HTX-A), comparing the outcomes with those of HTXpatients. (2) Methods: Electronic databases of PubMed, EMBASE, and SCOPUS were searched. The endpoints were as follows: the overall rate of postprocedural TR (immediate, one week, six months, and one year after the procedure), postoperative complications (permanent pacemaker implantation rate, bleeding), redo surgery for TR, and mortality. (3) Results: This meta-analysis included seven studies. Immediate postprocedural, one-week, six-month and one-year tricuspid insufficiency rates were significantly lower in the HTX-A group. There was no difference in permanent pacemaker implantation rate between the groups. The incidence of postoperative bleeding was similar in both arms. The rate of redo surgery for severe TR was reported only by two authors. In both publications, the total number of events was higher in the HTX cohort, meanwhile pooled effect analysis showed no difference among the intervention and control groups. Mortality at one year was similar in both arms. (4) Conclusion: Our study showed that donor heart TA reduces TR incidence in the first year after orthotopic heart transplantation without increasing the surgical complexity. This is a potentially important issue, given the demand for heart transplants and the need to optimize outcomes when this resource is scarce.
Authors: M C Chan; N Giannetti; T Kato; M Kornbluth; P Oyer; H A Valantine; R C Robbins; S A Hunt Journal: J Heart Lung Transplant Date: 2001-07 Impact factor: 10.247
Authors: Francesco Scardulla; Valentina Agnese; Giuseppe Romano; Gabriele Di Gesaro; Sergio Sciacca; Diego Bellavia; Francesco Clemenza; Michele Pilato; Salvatore Pasta Journal: Cardiovasc Eng Technol Date: 2018-04-26 Impact factor: 2.495
Authors: A D Bainbridge; M Cave; M Roberts; R Casula; B A Mist; J Parameshwar; J Wallwork; S R Large Journal: J Heart Lung Transplant Date: 1999-05 Impact factor: 10.247
Authors: A I Fiorelli; N A G Stolf; C A C Abreu Filho; R H B Santos; F H A Buco; L R Fiorelli; V Issa; F Bacal; E A Bocchi Journal: Transplant Proc Date: 2007-10 Impact factor: 1.066
Authors: Geoffrey A Rubin; Joseph Sanchez; Joseph Bayne; Uma Mahesh R Avula; Hiroo Takayama; Koji Takeda; Yoshifumi Naka; Hasan Garan; Maryjane A Farr; Elaine Y Wan Journal: ASAIO J Date: 2019 Sep/Oct Impact factor: 2.872